Medicus Sciences Acquisition Corp. Warrant
MSACW
MSACW was delisted on the 17th of February, 2023.
17 hedge funds and large institutions have $975K invested in Medicus Sciences Acquisition Corp. Warrant in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$69.5K |
| 2 |
TP
Third Point
New York
|
+$69.5K |
| 3 |
HM
HealthCor Management
New York
|
+$65.5K |
| 4 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$52.8K |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$45.8K |
Top Sellers
MSACW Hedge Fund Activity: Q2 2021 in Review
17 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Warrant (MSACW) for Q2 2021, worth a combined $975K.
Buyers outnumbered sellers: 17 funds opened new MSACW positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $69.5K.
- 17 institutional investors held Medicus Sciences Acquisition Corp. Warrant (MSACW) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $975K of Medicus Sciences Acquisition Corp. Warrant stock for Q2 2021.
- 17 funds opened new Medicus Sciences Acquisition Corp. Warrant positions in Q2 2021 and 0 closed out, a net change of +17 holders.
- The largest Medicus Sciences Acquisition Corp. Warrant buyer in Q2 2021 was Adage Capital Partners, an estimated $69.5K added.
Based on aggregated 13F filings for Q2 2021.